Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI

Clinical trial NCT01005251 · COMPLETED

Trial details

NCT number: NCT01005251
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease Heartburn Regurgitation

Start date: 2009-10-01
Primary completion: 2010-07-01
Enrollment: 661

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.